An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before redirecting customers to other platforms for purchases.
Understanding Retatrutide
This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals administering products of unknown origin.
Several experts stated the popularity for the experimental drug could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.
Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, advertising, and customer regulations, risking fines, legal action or prison.
Platform Reaction and Content Elimination
According to the social media company, the service has taken down problematic material and banned related keywords and query recommendations. The organization stated it was dedicated to keeping the service secure and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Research also discovered groups with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, filled with images of weight loss, glowing reviews and step-by-step guides for mixing or injecting at home.
Within minutes of entering one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.
Item Information and Pricing
Inside these communities, messages display black plastic parcels with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When asked how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service stated it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Even if the research behind retatrutide is sound, these online versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.
Her staff has previously seen patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental product not yet authorized … may subject patients to potentially serious health risks”.
